The Interplay between Host Immunity and Respiratory Viral Infection in Asthma Exacerbation

키워드

참고문헌 (119)

1. Anderson GP, "Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease", Lancet, 372, pp.1107~1119 (2008)
2. Pawankar R, "Allergic diseases and asthma: a global public health concern and a call to action", World Allergy Organ J, 7, pp.12~ (2014)
3. Zedan M, "Clinical asthma phenotypes and therapeutic responses", ISRN Pediatr, 2013, pp.824781~ (2013)
4. Wenzel SE, "Asthma phenotypes: the evolution from clinical to molecular approaches", Nat Med, 18, pp.716~725 (2012)
5. Lambrecht BN, "The immunology of asthma", Nat Immunol, 16, pp.45~56 (2015)
6. Agache I, "Non-eosinophilic asthma endotypes", Curr Treat Options Allergy, 2, pp.257~267 (2015)
7. Jackson DJ, "The role of viruses in acute exacerbations of asthma", J Allergy Clin Immunol, 125, pp.1178~1187 (2010)
8. Miller EK, "Rhinovirus-associated hospitalizations in young children", J Infect Dis, 195, pp.773~781 (2007)
9. Wark PA, "Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus", J Exp Med, 201, pp.937~947 (2005)
10. Contoli M, "Role of deficient type III interferon-lambda production in asthma exacerbations", Nat Med, 12, pp.1023~1026 (2006)
11. Green RM, "Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study", BMJ, 324, pp.763~ (2002)
12. Khetsuriani N, "Prevalence of viral respiratory tract infections in children with asthma", J Allergy Clin Immunol, 119, pp.314~321 (2007)
13. Hu X, "Respiratory syncytial virus exacerbates OVA-mediated asthma in mice through C5a-C5aR regulating CD4+T cells immune responses", Sci Rep, 7, pp.15207~ (2017)
14. Message SD, "Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1", 2 cytokine and IL-10 production, 2008, pp.105, 13562~13567
15. Busse WW, "Role of viral respiratory infections in asthma and asthma exacerbations", Lancet, 376, pp.826~834 (2010)
16. Yılmaz İ, "Is Asthma-COPD overlap an asthma phenotype or a COPD phenotype?", Tuberk Toraks, 66, pp.78~79 (2018)
17. Bartlett NW, "Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation", Nat Med, 14, pp.199~204 (2008)
18. Whitsett JA, "Respiratory epithelial cells orchestrate pulmonary innate immunity", Nat Immunol, 16, pp.27~35 (2015)
19. Barnes PJ, "Immunology of asthma and chronic obstructive pulmonary disease", Nat Rev Immunol, 8, pp.183~192 (2008)
20. Woodruff PG, "T-helper type 2-driven inflammation defines major subphenotypes of asthma", Am J Respir Crit Care Med, 180, pp.388~395 (2009)
21. Ramsahai JM, "Mechanisms and management of asthma exacerbations", Am J Respir Crit Care Med, 199, pp.423~432 (2019)
22. Shi YH, "Coexistence of Th1", Th2 and Th17, Chin Med J (Engl), pp.2011, 124[DOI]
23. Simpson JL, "Innate immune activation in neutrophilic asthma and bronchiectasis", Thorax, 62, pp.211~218 (2007)
24. Kim RY, "MicroRNA-21 drives severe, steroid-insensitive experimental asthma by amplifying phosphoinositide 3-kinase-mediated suppression of histone deacetylase 2", J Allergy Clin Immunol, 139, pp.519~532 (2017)
25. Kim RY, "Role for nlrp3 inflammasome-mediated, il-1beta-dependent responses in severe, steroid-resistant asthma", Am J Respir Crit Care Med, 196, pp.283~297 (2017)
26. Zhang N, "Glucocorticoids enhance or spare innate immunity: effects in airway epithelium are mediated by CCAAT", enhancer binding proteins, 2007, pp.179, 578~589
27. Busse W, "Anti-IL-5 treatments in patients with severe asthma by blood eosinophil thresholds: Indirect treatment comparison", J Allergy Clin Immunol, 143, pp.190~200.e20 (2019)
28. Macedo P, "Inflammatory biomarkers in airways of patients with severe asthma compared with non-severe asthma", Clin Exp Allergy, 39, pp.1668~1676 (2009)
29. Papi A, "Rhinovirus infection causes steroid resistance in airway epithelium through nuclear factor κB and c-Jun N-terminal kinase activation", J Allergy Clin Immunol, 132, pp.1075~1085.e6 (2013)
30. Stone JK, "A morpholino oligomer targeting highly conserved internal ribosome entry site sequence is able to inhibit multiple species of picornavirus", Antimicrob Agents Chemother, 52, pp.1970~1981 (2008)
31. Cakebread JA, "Exogenous IFN-β has antiviral and anti-inflammatory properties in primary bronchial epithelial cells from asthmatic subjects exposed to rhinovirus", J Allergy Clin Immunol, 127, pp.1148~1154.e9 (2011)
32. Barnes PJ, "Targeting cytokines to treat asthma and chronic obstructive pulmonary disease", Nat Rev Immunol, 18, pp.454~466 (2018)
33. Kaminuma O, "Selective down-regulation of Th2 cell-mediated airway inflammation in mice by pharmacological intervention of CCR4", Clin Exp Allergy, 42, pp.315~325 (2012)
34. Kara EE, "Distinct chemokine receptor axes regulate Th9 cell trafficking to allergic and autoimmune inflammatory sites", J Immunol, 191, pp.1110~1117 (2013)
35. Samarasinghe AE, "The immune profile associated with acute allergic asthma accelerates clearance of influenza virus", Immunol Cell Biol, 92, pp.449~459 (2014)
36. Rydell-Törmänen K, "The applicability of mouse models to the study of human disease", Methods Mol Biol, 1940, pp.3~22 (2019)
37. Nagarkar DR, "Rhinovirus infection of allergen-sensitized and -challenged mice induces eotaxin release from functionally polarized macrophages", J Immunol, 185, pp.2525~2535 (2010)
38. Tan HT, "Tight junction, mucin, and inflammasome-related molecules are differentially expressed in eosinophilic, mixed, and neutrophilic experimental asthma in mice", Allergy, 74, pp.294~307 (2019)
39. Kumar RK, "The “classical” ovalbumin challenge model of asthma in mice", Curr Drug Targets, 9, pp.485~494 (2008)
40. Sajjan U, "Rhinovirus disrupts the barrier function of polarized airway epithelial cells", Am J Respir Crit Care Med, 178, pp.1271~1281 (2008)
41. Slater L, "Co-ordinated role of TLR3, RIG-I and MDA5 in the innate response to rhinovirus in bronchial epithelium", PLoS Pathog, 6, pp.e1001178~ (2010)
42. Zhu J, "Bronchial mucosal IFN-α", β and pattern recognition receptor expression in patients with experimental rhinovirus-induced asthma exacerbations, 2019, pp.143, 114~125.e4
43. Goulopoulou S, "Toll-like receptors in the vascular system: Sensing the dangers within", Pharmacol Rev, 68, pp.142~167 (2016)
44. Yamamoto M, "Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway", Science, 301, pp.640~643 (2003)
45. Kalthoum Tizaoui, "Association of Single Nucleotide Polymorphisms in Toll-like Receptor Genes With Asthma Risk: A Systematic Review and Meta-analysis", Allergy, Asthma & Immunology Research, 7(2), pp.130~140 (2015), 대한천식알레르기학회
46. Zuo L, "Molecular regulation of toll-like receptors in asthma and COPD", Front Physiol, 6, pp.312~ (2015)
47. Frotscher B, "Inhibition of IgE production by the imidazoquinoline resiquimod in nonallergic and allergic donors", J Invest Dermatol, 119, pp.1059~1064 (2002)
48. Yoneyama M, "Shared and unique functions of the DExD", H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity, 2005, pp.175, 2851~2858
49. Tan KS, "In vitro model of fully differentiated human nasal epithelial cells infected with rhinovirus reveals epithelium-initiated immune responses", J Infect Dis, 217, pp.906~915 (2018)
50. Triantafilou K, "Human rhinovirus recognition in non-immune cells is mediated by Toll-like receptors and MDA-5, which trigger a synergetic pro-inflammatory immune response", Virulence, 2, pp.22~29 (2011)
51. Boldogh I, "ROS generated by pollen NADPH oxidase provide a signal that augments antigen-induced allergic airway inflammation", J Clin Invest, 115, pp.2169~2179 (2005)
52. Zhu J, "Airway inflammation and illness severity in response to experimental rhinovirus infection in asthma", Chest, 145, pp.1219~1229 (2014)
53. Contoli M, "Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells", Allergy, 70, pp.910~920 (2015)
54. Xiao C, "Defective epithelial barrier function in asthma", J Allergy Clin Immunol, 128, pp.549~556.e1-12 (2011)
55. Chang YJ, "Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity", Nat Immunol, 12, pp.631~638 (2011)
56. Ckless K, "Epithelial, dendritic, and CD4+ T cell regulation of and by reactive oxygen and nitrogen species in allergic sensitization", Biochim Biophys Acta, 1810, pp.1025~1034 (2011)
57. Schmidt LM, "Bronchial epithelial cell-derived prostaglandin E2 dampens the reactivity of dendritic cells", J Immunol, 186, pp.2095~2105 (2011)
58. Fahy JV, "Type 2 inflammation in asthma--present in most, absent in many", Nat Rev Immunol, 15, pp.57~65 (2015)
59. Bankova LG, "The cysteinyl leukotriene 3 receptor regulates expansion of IL-25-producing airway brush cells leading to type 2 inflammation", Sci Immunol, 3, pp.9453~ (2018)
60. Jackson DJ, "IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo", Am J Respir Crit Care Med, 190, pp.1373~1382 (2014)
61. Akuthota P, "Eosinophils as antigen-presenting cells in allergic upper airway disease", Curr Opin Allergy Clin Immunol, 10, pp.14~19 (2010)
62. Snelgrove RJ, "The enigmatic role of the neutrophil in asthma: Friend, foe or indifferent", Clin Exp Allergy, 48, pp.1275~1285 (2018)
63. Toussaint M, "Host DNA released by NETosis promotes rhinovirus-induced type-2 allergic asthma exacerbation", Nat Med, 23, pp.681~691 (2017)
64. Busse WW, "A role for neutrophils in asthma exacerbations", Nat Med, 23, pp.658~659 (2017)
65. Lee YG, "Recruited alveolar macrophages, in response to airway epithelial-derived monocyte chemoattractant protein 1", CCl2, regulate airway inflammation and remodeling in allergic asthma, 2015, pp.52, 772~784
66. Nomura H, "Histamine stimulates alveolar macrophages to release neutrophil and monocyte chemotactic activity", J Lab Clin Med, 138, pp.226~235 (2001)
67. Subauste MC, "Infection of a human respiratory epithelial cell line with rhinovirus. Induction of cytokine release and modulation of susceptibility to infection by cytokine exposure", J Clin Invest, 96, pp.549~557 (1995)
68. Hong JY, "Macrophage activation state determines the response to rhinovirus infection in a mouse model of allergic asthma", Respir Res, 15, pp.63~ (2014)
69. Chung Y, "Rhinovirus infection induces interleukin-13 production from CD11b-positive, M2-polarized exudative macrophages", Am J Respir Cell Mol Biol, 52, pp.205~216 (2015)
70. Nakasone C, "Accumulation of gamma", delta T cells in the lungs and their roles in neutrophil-mediated host defense against pneumococcal infection, 2007, pp.9, 251~258
71. Glanville N, "γδT cells suppress inflammation and disease during rhinovirus-induced asthma exacerbations", Mucosal Immunol, 6, pp.1091~1100 (2013)
72. Yang X, "Imbalance of γδT17", γδTreg cells in the pathogenesis of allergic asthma induced by ovalbumin, 2018, pp.51, e7127~
73. Kim SW, "Effect of roflumilast on airway remodelling in a murine model of chronic asthma", Clin Exp Allergy, 46, pp.754~763 (2016)
74. Hammad H, "Barrier epithelial cells and the control of type 2 immunity", mmunity, 43, pp.29~40 (2015)
75. Kim J, "Innate immune crosstalk in asthmatic airways: Innate lymphoid cells coordinate polarization of lung macrophages", J Allergy Clin Immunol, 143, pp.1769~1782.e11 (2019)
76. Verma M, "Experimental asthma persists in IL-33 receptor knockout mice because of the emergence of thymic stromal lymphopoietin-driven IL-9+ and IL-13+ type 2 innate lymphoid cell subpopulations", J Allergy Clin Immunol, 142, pp.793~803.e8 (2018)
77. Saenz SA, "IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses", Nature, 464, pp.1362~1366 (2010)
78. Bando JK, "The tumor necrosis factor superfamily member RANKL suppresses effector cytokine production in group 3 innate lymphoid cells", Immunity, 48, pp.1208~1219.e4 (2018)
79. Ivashkiv LB, "Regulation of type I interferon responses", Nat Rev Immunol, 14, pp.36~49 (2014)
80. Bhakta NR, "IFN-stimulated gene expression, type 2 inflammation, and endoplasmic reticulum stress in asthma", Am J Respir Crit Care Med, 197, pp.313~324 (2018)
81. Edwards MR, "Impaired innate interferon induction in severe therapy resistant atopic asthmatic children", Mucosal Immunol, 6, pp.797~806 (2013)
82. Kikkawa Y, "Interferon-alpha inhibits airway eosinophilia and hyperresponsiveness in an animal asthma model", Asia Pac Allergy, 2, pp.256~263 (2012)
83. Baraldo S, "Deficient antiviral immune responses in childhood: distinct roles of atopy and asthma", J Allergy Clin Immunol, 130, pp.1307~1314 (2012)
84. Fulkerson PC, "Negative regulation of eosinophil recruitment to the lung by the chemokine monokine induced by IFN-gamma (Mig, CXCL9)", Proc Natl Acad Sci U S A, 101, pp.1987~1992 (2004)
85. Coyle AJ, "Mice lacking the IFN-gamma receptor have impaired ability to resolve a lung eosinophilic inflammatory response associated with a prolonged capacity of T cells to exhibit a Th2 cytokine profile", J Immunol, 156, pp.2680~2685 (1996)
86. Boehm U, "Cellular responses to interferon-gamma", Annu Rev Immunol, 15, pp.749~795 (1997)
87. Sehra S, "Airway IgG counteracts specific and bystander allergen-triggered pulmonary inflammation by a mechanism dependent on Fc gamma R and IFN-gamma", J Immunol, 171, pp.2080~2089 (2003)
88. Spann KM, "Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages", J Virol, 78, pp.4363~4369 (2004)
89. Yang K, "Human TLR-7-, -8-, and -9-mediated induction of IFN-alpha", beta and -lambda Is IRAK-4 dependent and redundant for protective immunity to viruses, 2005, pp.23, 465~478
90. Sykes A, "Rhinovirus 16-induced IFN-α and IFN-β are deficient in bronchoalveolar lavage cells in asthmatic patients", J Allergy Clin Immunol, 129, pp.1506~1514 (2012)
91. Lasfar A, "IFN-lambda therapy: current status and future perspectives", Drug Discov Today, 21, pp.167~171 (2016)
92. Cannons JL, "Lymph node choreography: B cells take the lead", Nat Immunol, 13, pp.630~632 (2012)
93. Altin J, "Understanding the genetic regulation of IgE production", Blood Rev, 24, pp.163~169 (2010)
94. Sallmann E, "High-affinity IgE receptors on dendritic cells exacerbate Th2-dependent inflammation", J Immunol, 187, pp.164~171 (2011)
95. Lindell DM, "B cell antigen presentation promotes Th2 responses and immunopathology during chronic allergic lung disease", PLoS One, 3, pp.e3129~ (2008)
96. Harris DP, "Reciprocal regulation of polarized cytokine production by effector B and T cells", Nat Immunol, 1, pp.475~482 (2000)
97. Lund FE, "Effector and regulatory B cells: modulators of CD4+ T cell immunity", Nat Rev Immunol, 10, pp.236~247 (2010)
98. Nakamura Y, "Gene expression of the GATA-3 transcription factor is increased in atopic asthma", J Allergy Clin Immunol, 103, pp.215~222 (1999)
99. Lambrecht BN, "The cytokines of asthma", Immunity, 50, pp.975~991 (2019)
100. Ngoc PL, "Cytokines, allergy, and asthma", Curr Opin Allergy Clin Immunol, 5, pp.161~166 (2005)
101. Alcorn JF, "Th17 cells in asthma and COPD", Annu Rev Physiol, 72, pp.495~516 (2010)
102. Korn T, "IL-17 and Th17 cells", Annu Rev Immunol, 27, pp.485~517 (2009)
103. Choy DF, "Th2 and Th17 inflammatory pathways are reciprocally regulated in asthma", Sci Transl Med, 7(301) (2015)
104. Schnyder-Candrian S, "Interleukin-17 is a negative regulator of established allergic asthma", J Exp Med, 203, pp.2715~2725 (2006)
105. Barlow JL, "Reciprocal expression of IL-25 and IL-17A is important for allergic airways hyperreactivity", Clin Exp Allergy, 41, pp.1447~1455 (2011)
106. Wakashin H, "IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice", Am J Respir Crit Care Med, 178, pp.1023~1032 (2008)
107. Besnard AG, "Dual role of IL-22 in allergic airway inflammation and its cross-talk with IL-17A", Am J Respir Crit Care Med, 183, pp.1153~1163 (2011)
108. Takahashi K, "IL-22 attenuates IL-25 production by lung epithelial cells and inhibits antigen-induced eosinophilic airway inflammation", J Allergy Clin Immunol, 128, pp.1067~1076.e1-6 (2011)
109. Veldhoen M, "Transforming growth factor-beta ‘reprograms’ the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset", Nat Immunol, 9, pp.1341~1346 (2008)
110. Matsuzawa S, "IL-9 enhances the growth of human mast cell progenitors under stimulation with stem cell factor", J Immunol, 170, pp.3461~3467 (2003)
111. Saeki M, "Th9 cells elicit eosinophil-independent bronchial hyperresponsiveness in mice", Allergol Int, 65(Suppl), pp.S24~S29 (2016)
112. 최인선, "Immune Tolerance by Induced Regulatory T Cells in Asthma", Allergy, Asthma & Immunology Research, 4(3), pp.113~115 (2012), 대한천식알레르기학회[DOI]
113. Vignali DA, "How regulatory T cells work", Nat Rev Immunol, 8, pp.523~532 (2008)
114. Andersson J, "CD4+ FoxP3+ regulatory T cells confer infectious tolerance in a TGF-beta-dependent manner", J Exp Med, 205, pp.1975~1981 (2008)
115. Kearley J, "CD4+CD25+ regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling", J Allergy Clin Immunol, 122, pp.617~624.e6 (2008)
116. Sather BD, "Altering the distribution of Foxp3+ regulatory T cells results in tissue-specific inflammatory disease", J Exp Med, 204, pp.1335~1347 (2007)
117. Akbari O, "Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity", Nat Med, 8, pp.1024~1032 (2002)
118. Ali FR, "Late asthmatic reactions induced by inhalation of allergen-derived T cell peptides", Am J Respir Crit Care Med, 169, pp.20~26 (2004)
119. Kim JH, "CCR5 ameliorates Japanese encephalitis via dictating the equilibrium of regulatory CD4+Foxp3+ T and IL-17+CD4+ Th17 cells", J Neuroinflammation, 13, pp.223~ (2016)

관련 논문AI추천